Lupin today announced that it has received tentative approval from the United States Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA Drospirenone Tablets 4 mg to market a generic equivalent of Slynd Tablets 4 mg of Exeltis USA Inc Drospirenone Tablets RLD Slynd had estimated annual sales of USD 141 million in the US IQVIA MAT September 2022
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
